Sai Parenterals IPO

Company Name: Sai Parenterals Limited

Industry / Sector: Pharmaceuticals / Branded Generics & CDMO (Injectables, Tablets, Capsules, etc.)

Founded Year: 2001

Promoters: Anil Kumar Karusala, Vijitha Gorrepati, Karusala Aruna

Incorporated in 2001, Sai Parenterals Limited is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing. It operates in two segments: Branded Generic Formulations and Contract Development and Manufacturing Organisation (CDMO) products and services for domestic and international markets. The product portfolio spans multiple therapeutic areas including cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins/minerals/supplements (VMS), analgesics, and dermatology. Offerings are across dosage forms such as injectables, tablets, capsules, liquid orals, and ointments. The company serves central and state government agencies, pharmaceutical companies, public and private hospitals, and super stockists in India. It entered exports in FY2023 after acquiring two internationally accredited facilities in Hyderabad and now supplies to regulated and semi-regulated markets in Australia, New Zealand, Southeast Asia, the Middle East, and Africa. The company owns and operates five manufacturing facilities in India (four in Hyderabad, Telangana and one in Ongole, Andhra Pradesh via subsidiary Revat Laboratories). As of December 31, 2025, it employed 298 full-time employees.